Urethral condyloma acuminata in a male patient refractory to common topical treatments: A case report

Refractory urethral condyloma acuminata

Authors

  • Devi Artami Susetiati Department of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada

DOI:

https://doi.org/10.66344/jpad.31.4.2021.1729

Abstract

Condyloma acuminata is one of the most prevalent sexually transmitted diseases caused by human papilloma virus (HPV). Urethral involvement of condyloma acuminata is uncommon and more challenging to treat. Despite more condylomas are associated with the low-risk HPV (e.g., types 6 and 11), histopathologic examination is sometimes needed to exclude malignant process, especially in a lesion with atypical form or unresponsive to the standard therapy. Here we report a unique case of urethral condyloma acuminata in a male patient that refractory to the common condyloma topical treatments.

Downloads

Published

2022-03-29

How to Cite

1.
Susetiati DA. Urethral condyloma acuminata in a male patient refractory to common topical treatments: A case report: Refractory urethral condyloma acuminata. J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026Apr.12];31(4):763-6. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1729

Issue

Vol. 31 No. 4 (2021): October - December

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.